| Roanoke Valley Speech And Hearing Center, Inc. | |
|
2030 Colonial Ave Sw, Roanoke, VA 24015-3204 | |
| (540) 343-0165 | |
| (540) 345-4664 |
| Full Name | Roanoke Valley Speech And Hearing Center, Inc. |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 2030 Colonial Ave Sw, Roanoke, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386837250 | NPI | - | NPPES |
| 247018 | Other | VA | ANTHEM |
| 7602827 | Other | VA | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 2201000601 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Roanoke Valley Speech And Hearing Center, Inc. 2030 Colonial Ave Sw, Roanoke, VA 24015-3204 Ph: (540) 343-0165 | Roanoke Valley Speech And Hearing Center, Inc. 2030 Colonial Ave Sw, Roanoke, VA 24015-3204 Ph: (540) 343-0165 |
News Archive
Space is one of the most demanding and unforgiving environments. Human exploration of space requires astronauts to maintain consistently high levels of cognitive performance to ensure mission safety and success, and prevent potential errors and accidents. Despite the importance of cognitive performance for mission success, little is known about how cognition is affected by prolonged spaceflight, and what aspects of cognition are primarily affected.
QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.
As the search for effective antivirals against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues, a new study published on the preprint bioRxiv in November 2020 discusses the role of synthetic nanobodies or sybodies in neutralizing the virus by binding to its receptor-binding domain (RBD) on the spike protein.
A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to new research in the American Heart Association's journal Hypertension.
› Verified 3 days ago
Kevin E Mccurdy, CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 325 Elm Ave Se, Roanoke, VA 24013 Phone: 540-343-5567 | |
Kristina S Miller, AU.D., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-224-5170 | |
Tammy Brooks Garber, M.S. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2155 Electric Rd, Suite C, Roanoke, VA 24018 Phone: 540-774-4441 Fax: 540-774-3393 | |
Mrs. Heather B Dickey, MSCCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2030 Colonial Ave Sw, Roanoke, VA 24015 Phone: 540-343-0165 Fax: 540-343-4664 | |
Michelle Ann Ickes, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2030 Colonial Ave Sw, Roanoke, VA 24015 Phone: 540-343-0165 | |
Hearing Health Associates, Pc Audiologist Medicare: Medicare Enrolled Practice Location: 2155 Electric Rd, Suite C, Roanoke, VA 24018 Phone: 540-774-4441 Fax: 540-774-3393 |